Prevention of pregnancy and sickness after a sustained method of conservative myomectomy
The number of surgical interventions in the uterus, including conservative myomectomy in women of reproductive age, has increased significantly, and, accordingly, the percentage of patients with a scar on the uterus has increased. It is difficult for women to make a pregnancy plan, to determine the best way and time of delivery. After the performed myomectomy, pregnancy planning is required not earlier than 6 months after the operation (provided the normal state of health and absence of complications). The peculiarity of the course of pregnancy after myomectomy is the presence of scarring on the uterus, and the importance of the volume and nature of the operation performed. Childbirth through natural birth lines can be resolved by specialists in the following cases: in the absence of exacerbations in the recovery period; if laboratory-instrumental studies confirm the fact of the fullness of the lower segment of the uterus; at placental placenta outside the scar tissue of the uterus; when the mother's pelvis matches the fetal head; with obligatory tracking of childbirth process using monitors; if possible, a cesarean section urgently, but not later than fifteen minutes after the decision to intervene. We proposed innovative approach is conservative myomectomy performed using electrosurgical techniques (argon plasma coagulation and radio wave scalpel) and such medications as Terlipressin (synthetic analogue of vasopressin), Defensal (anti-adhesion barrier). The conducted clinical research has determined the effectiveness of the complex method of surgical treatment of uterine leiomyomas with the use of modern drugs and technical support for the improvement of reproductive function in treated women.
2. Bazanov, P. A. & Volkov, N. I. (2012). Mioma matki i narusheniya reproduktivnoj funkcii. [Uterine fibroids and reproductive disorders]. Problemy reprodukcii – Reproduction problems, 4 (8), 16–8.
3. Buyanova, S. N., Logutova, L. S. & Babunashvili, E. L. (2013). Reproduktivnyj prognoz pri miome matki. [Reproductive prognosis for uterine myoma]. Rossijskij vestnik akushera-ginekologa – The Russian bulletin of the obstetrician-gynecologist, 3 (4), 47–9.
4. Vihlyaeva, E. M. (2010). O strategii i taktike vedeniya bolnyh s miomoj matki. [On the strategy and tactics of managing patients with uterine myoma]. Vestnik Rossijskoj associacii akusherov-ginekologov – Bulletin of the Russian Association of Obstetricians and Gynecologists, 3, 21–2.
5. Andersen, J. (2010). Growth factors and cytokines in uterine leiomyomas. Semin. Reprod. Endocrinol., 14 (3), 269–82. DOI: 10.1055/s-2007-1016336.
6. Bendifallah, S., Brun, J. L. & Fernandez, H. J. (2011). Myomectomy for infertile women: the role of surgery. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction, 40 (8), 885–901. DOI: 10.1016/j.jgyn.2011.09.014.
7. Candiani, G. B. & Fedele, L. (2011). Risk of recurrence after myomectomy. Br. J. Obstet. Gynaecol., 98 (4), 385–9. https://doi.org/10.1111/j.1471-0528.1991.tb13429.x.
8. Fauconnier, A. & Chapron, C. (2010). Recurrence of leiomyomata after myomectomy. Human Reproduction Update, 6 (6), 595–602.
9. Li, T. C., Mortimer, R. & Cooke, I. D. (1999). Myomectomy: a retrospective study to examine reproductive performance before and after surgery. Hum. Reprod., 14 (7), 1735–1740.
10. Rolli, R., Favilli, A., Acanfora, M. M., Scuderi, G., Di Renzo, G. C. & Gerli, S. (2012). Vaginal myomectomy is a safe and feasible procedure: A retrospective study of 46 cases. J. Obstet. Gynaecol. Res., 38 (9), 1201–1205. doi:10.1111/j.1447-0756.2012.01852.x.
This work is licensed under a Creative Commons Attribution 4.0 International License.